Literature DB >> 15261336

Altered structure of autoantigens during apoptosis.

John C Hall1, Livia Casciola-Rosen, Antony Rosen.   

Abstract

The clustering and concentration of autoantigens at the surface of apoptotic cells, in combination with the striking tolerance-inducing function of apoptotic cells, have focused attention on abnormalities in apoptotic cell execution and clearance as potential susceptibility and initiating factors in systemic autoimmunity. Structural changes that occur during cell death may influence the immunogenicity of self antigens. This article discusses the modifications that autoantigens undergo during cell death, identifies certain proimmune forms of apoptotic death in which autoantigen structure is frequently modified, and reviews the mechanisms through which such structural changes might lead to initiation of an autoimmune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261336     DOI: 10.1016/j.rdc.2004.04.012

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  27 in total

1.  Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs.

Authors:  Indira Neeli; Mekel M Richardson; Salar N Khan; Danielle Nicolo; Marc Monestier; Marko Z Radic
Journal:  Mol Immunol       Date:  2006-11-03       Impact factor: 4.407

Review 2.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

3.  The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.

Authors:  Chen Li; Hye-Yeung Kim; Huy Vuong; Tasneem Patwa; Manoj Pal; Randall E Brand; Diane M Simeone; David M Lubman
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Heterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases.

Authors:  Marko Z Radic; Kinjal Shah; Wenguang Zhang; Qingxian Lu; Greg Lemke; George M Hilliard
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 5.  Tumor-associated antigen arrays for the serological diagnosis of cancer.

Authors:  Carlos A Casiano; Melanie Mediavilla-Varela; Eng M Tan
Journal:  Mol Cell Proteomics       Date:  2006-05-29       Impact factor: 5.911

Review 6.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

Review 7.  Granzyme B cleavage of autoantigens in autoimmunity.

Authors:  E Darrah; A Rosen
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

Review 8.  Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors.

Authors:  Giuseppe Murdaca; Francesca Spanò; Paola Cagnati; Francesco Puppo
Journal:  Redox Rep       Date:  2013-05-10       Impact factor: 4.412

9.  The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.

Authors:  Tamar Aprahamian; Ramon G Bonegio; Christophe Richez; Kei Yasuda; Lo-Ku Chiang; Kaori Sato; Kenneth Walsh; Ian R Rifkin
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.

Authors:  Christopher Richardson; Asiya Seema Chida; Diana Adlowitz; Lin Silver; Erin Fox; Scott A Jenks; Elise Palmer; Youliang Wang; Jamie Heimburg-Molinaro; Quan-Zhen Li; Chandra Mohan; Richard Cummings; Christopher Tipton; Ignacio Sanz
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.